mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.06 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.07 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.07 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |